RxNorm Semantic Concepts Index - 301
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "301".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 30111 | MMDA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 30111 | MMDA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3012 | Cymarin | Designated preferred name (PT) | NO | |
| RxCUI: 3012 | Cymarin | Full form of descriptor (FN) | NO | |
| RxCUI: 30121 | Moclobemide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 30121 | Moclobemide | Designated preferred name (PT) | NO | |
| RxCUI: 30121 | Moclobemide | Full form of descriptor (FN) | NO | |
| RxCUI: 30121 | Moclobemide | Designated preferred name (PT) | NO | |
| RxCUI: 30121 | Moclobemide | Full form of descriptor (FN) | NO | |
| RxCUI: 30125 | modafinil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 30125 | modafinil | Designated preferred name (PT) | YES | |
| RxCUI: 30125 | modafinil | Full form of descriptor (FN) | YES | |
| RxCUI: 30125 | modafinil | Designated preferred name (PT) | YES | |
| RxCUI: 30125 | modafinil | Full form of descriptor (FN) | YES | |
| RxCUI: 30129 | Fluophenazine enanthate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 30129 | Fluophenazine enanthate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 30129 | Fluophenazine enanthate | Designated preferred name (PT) | NO | |
| RxCUI: 30129 | Fluophenazine enanthate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 30129 | Fluophenazine enanthate | Full form of descriptor (FN) | NO | |
| RxCUI: 3013 | Cyproheptadine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 3013 | Cyproheptadine | Designated preferred name (PT) | YES | |
| RxCUI: 3013 | Cyproheptadine | Full form of descriptor (FN) | YES | |
| RxCUI: 3013 | Cyproheptadine | Designated preferred name (PT) | YES | |
| RxCUI: 3013 | Cyproheptadine | Full form of descriptor (FN) | YES | |
| RxCUI: 30131 | moexipril | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 30131 | moexipril | Designated preferred name (PT) | YES | |
| RxCUI: 30131 | moexipril | Full form of descriptor (FN) | YES | |
| RxCUI: 30131 | moexipril | Designated preferred name (PT) | YES | |
| RxCUI: 30131 | moexipril | Full form of descriptor (FN) | YES | |
| RxCUI: 301331 | Lethal factor | Designated preferred name (PT) | NO | |
| RxCUI: 301331 | Lethal factor | Full form of descriptor (FN) | NO | |
| RxCUI: 301331 | Lethal factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 301331 | Lethal factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3014 | Cyproterone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 3014 | Cyproterone | Designated preferred name (PT) | NO | |
| RxCUI: 3014 | Cyproterone | Full form of descriptor (FN) | NO | |
| RxCUI: 3014 | Cyproterone | Designated preferred name (PT) | NO | |
| RxCUI: 3014 | Cyproterone | Full form of descriptor (FN) | NO | |
| RxCUI: 30145 | mometasone furoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 30145 | mometasone furoate | Designated preferred name (PT) | YES | |
| RxCUI: 30145 | mometasone furoate | Full form of descriptor (FN) | YES | |
| RxCUI: 301523 | Glycosphingolipid ceramide deacylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 301523 | Glycosphingolipid ceramide deacylase | Designated preferred name (PT) | NO | |
| RxCUI: 301523 | Glycosphingolipid ceramide deacylase | Full form of descriptor (FN) | NO | |
| RxCUI: 301542 | rosuvastatin | Full form of descriptor (FN) | YES | |
| RxCUI: 301542 | rosuvastatin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 301542 | rosuvastatin | Designated preferred name (PT) | YES | |
| RxCUI: 301542 | rosuvastatin | Full form of descriptor (FN) | YES | |
| RxCUI: 301542 | rosuvastatin | Designated preferred name (PT) | YES | |
| RxCUI: 301543 | Advair | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 30156 | Moniliformin | Designated preferred name (PT) | NO | |
| RxCUI: 30156 | Moniliformin | Full form of descriptor (FN) | NO | |
| RxCUI: 30166 | Monoacetyldapsone | Designated preferred name (PT) | NO | |
| RxCUI: 30166 | Monoacetyldapsone | Full form of descriptor (FN) | NO | |
| RxCUI: 3017 | Cystathionine | Designated preferred name (PT) | NO | |
| RxCUI: 3017 | Cystathionine | Full form of descriptor (FN) | NO | |
| RxCUI: 301739 | abarelix | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 301739 | abarelix | Designated preferred name (PT) | NO | |
| RxCUI: 301739 | abarelix | Full form of descriptor (FN) | NO | |
| RxCUI: 301739 | abarelix | Designated preferred name (PT) | NO | |
| RxCUI: 301739 | abarelix | Full form of descriptor (FN) | NO | |
| RxCUI: 30179 | Monodehydroascorbate reductase (reduced nicotinamide adenine dinucleotide) | Designated preferred name (PT) | NO | |
| RxCUI: 30179 | Monodehydroascorbate reductase (reduced nicotinamide adenine dinucleotide) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 30179 | Monodehydroascorbate reductase (reduced nicotinamide adenine dinucleotide) | Full form of descriptor (FN) | NO | |
| RxCUI: 3018 | Beta-thionase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3018 | Beta-thionase | Designated preferred name (PT) | NO | |
| RxCUI: 3018 | Beta-thionase | Full form of descriptor (FN) | NO | |
| RxCUI: 3018 | Beta-thionase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3018 | Beta-thionase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3018 | Beta-thionase | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 3019 | Cysteine desulfhydrase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3019 | Cysteine desulfhydrase | Designated preferred name (PT) | NO | |
| RxCUI: 3019 | Cysteine desulfhydrase | Full form of descriptor (FN) | NO | |
| RxCUI: 3019 | Cysteine desulfhydrase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3019 | Cysteine desulfhydrase | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 3019 | Cysteine desulfhydrase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3019 | Cysteine desulfhydrase | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 3019 | Cysteine desulfhydrase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3019 | Cysteine desulfhydrase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3019 | Cysteine desulfhydrase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 30193 | camphoric acid 1-methyl ester | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 30196 | Methcathinone | Designated preferred name (PT) | NO | |
| RxCUI: 30196 | Methcathinone | Full form of descriptor (FN) | NO | |
| RxCUI: 30198 | Monooctanoin | Designated preferred name (PT) | NO | |
| RxCUI: 30198 | Monooctanoin | Full form of descriptor (FN) | NO | |
| RxCUI: 30198 | Monooctanoin | Designated preferred name (PT) | NO | |
| RxCUI: 30198 | Monooctanoin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 30198 | Monooctanoin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 30198 | Monooctanoin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 30198 | Monooctanoin | Full form of descriptor (FN) | NO |